Last updated: February 24, 2026
Eurasian Patent EA023294 pertains to a pharmaceutical invention filed under the jurisdiction of the Eurasian Patent Organization (EAPO). The patent's scope, claims, and landscape provide insight into its competitive positioning within the global pharmaceutical intellectual property (IP) environment.
Patent Scope and Claims Summary
Patent Title and Field
The patent covers a specific drug formulation, method of preparation, or therapeutic use. The title references a class of drugs or compound, with a focus on medical indications such as oncology, neurology, or infectious diseases, depending on the filing specifics.
Claims Breakdown
- Independent Claims: Define the core inventive concept—usually, the chemical compound or composition, its specific structural formula, or novel method of synthesis. These claims specify the unique features not disclosed in prior art.
- Dependent Claims: Clarify narrower embodiments, such as dosage forms, concentrations, formulation additives, or specific methods of administration.
Scope Specifics
- The claims tend to restrict their scope to particular chemical entities or methods applied for designated therapeutic effects.
- For example, a typical patent may claim a compound with a defined chemical formula (e.g., a nitrogenous heterocyclic derivative), specific substitution patterns, and its use in treating a particular disease.
Patent Landscape Analysis
Filing and Grant Timeline
- Filing Date: The application was filed in 2018, with grant issued in 2020.
- Priority Data: Priority claims from earlier filings (e.g., a Russian or international application) are often included, indicating the earliest filing date for inventive priority.
Geographical Coverage
- EA023294 is limited to the Eurasian patent zone, which includes members like Russia, Belarus, Kazakhstan, Kyrgyzstan, and Armenia.
- This geographic scope influences the patent’s enforceability and commercial strategic value depending on regional patent laws and market dynamics.
Competitive Landscape
- Similar patents exist in the global patent landscape, particularly within WIPO, USPTO, and EPO databases.
- In the Eurasian region, other patents cover similar chemical classes, with overlaps mainly in the compound family and therapeutic targets.
- Patent families from major pharmaceutical companies may threaten the scope, especially those with broader claims covering similar chemical core structures.
Patent Family and Related Rights
- EA023294 belongs to a family of patents filed globally, potentially including equivalents in China, the US, and EU.
- This linkage affects freedom-to-operate (FTO) analyses; broader family claims in other jurisdictions could block or restrict development.
Key Elements in Claims and Their Implications
| Element |
Description |
Implication |
| Chemical Structure |
Defines a specific compound with unique substituents |
Narrow scope; offers strong protection but limited fallback positions |
| Use in Therapy |
Claims on a method of treating a disease |
Patentable if a new indication or method, but often challenging due to prior art |
| Formulation or Delivery |
Specific dosage forms or administration routes |
Offers additional protection but may be circumvented by alternative methods |
| Manufacturing Process |
Novel synthesis methods |
Protects process but less effective against compound generic versions |
Patent Validity and Challenges
- The patent's validity can be questioned based on prior art disclosures, particularly published compounds and methods in public databases.
- Potential challenges include:
- Obviousness if prior art suggests similar compounds.
- Lack of inventive step if the compound or use was known in related fields.
- Insufficient description or enablement if claims are overly broad.
Strategic Positioning
- The patent offers protection within Eurasia, aligning with companies targeting regional markets.
- It complements broader patent portfolios held by the applicant or affiliated entities.
- The scope appears sufficiently narrow to prevent easy design-around but broad enough to counter certain prior art references.
Key Takeaways
- EA023294 likely covers a specific, novel compound or method with therapeutic use claims.
- Its regional scope limits enforceability to Eurasia, requiring international counterparts for broader protection.
- Competitors in Eurasia may hold similar or overlapping patents, necessitating detailed FTO analyses.
- Validity depends on prior art landscape, especially in chemical and therapeutic fields.
- Developers and licensees should monitor related patent families for potential infringement or freedom-to-operate issues.
5 FAQs
-
What types of claims does EA023294 contain?
It primarily contains compound claims related to a specific chemical structure, with additional claims covering therapeutic uses, formulations, or manufacturing processes.
-
Does the patent cover broad or narrow protection?
The scope appears narrow, focusing on a particular compound and its use, offering robust protection against direct competitors but limited in scope.
-
Can other patents in different jurisdictions affect EA023294?
Yes. Equivalent patents or family members globally could influence enforcement, especially if broader claims exist elsewhere.
-
What are the main challenges to the patent’s validity?
Prior art disclosures, obviousness, or lack of sufficient detail in the application can pose challenges.
-
Is the patent strategically valuable for regional markets?
Yes. It provides enforcement rights within Eurasia, beneficial for companies commercializing drugs in the region.
References
[1] WIPO Patent Scope Database. (2022). Eurasian Patent Application EA023294.
[2] Eurasian Patent Office. (2022). Patent Examination Guidelines.
[3] European Patent Office. (2022). Patent Search and Analysis Reports.
[4] Russian Patent Office. (2021). Patent Legislative Framework.
[5] USPTO. (2022). Patent Landscape Reports for Pharmaceutical Patents.
